Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis
2017 · The Lancet Infectious Diseases · 5,832 citations
https://doi.org/10.1016/s1473-3099(17)30753-3
U
Ursula Theuretzbacher
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
110
Papers
14.4K
Citations
39
h-index
69
i10-index
Ursula Theuretzbacher is an academic researcher. The author has contributed to research in topics: Antibiotic Resistance in Bacteria & Antibiotics Pharmacokinetics and Efficacy & Antibiotic Use and Resistance. The author has an h-index of 39, co-authored 94 publications.
ORCID: 0000-0003-2116-7128Papers by this author
worksCritical analysis of antibacterial agents in clinical development
2020 · Nature Reviews Microbiology · 359 citations
https://doi.org/10.1038/s41579-020-0340-0
Reviving old antibiotics
2015 · Journal of Antimicrobial Chemotherapy · 97 citations
https://doi.org/10.1093/jac/dkv157
Expanding antibiotic, vaccine, and diagnostics development and access to tackle antimicrobial resistance
2024 · The Lancet · 95 citations
https://doi.org/10.1016/s0140-6736(24)00878-x
Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol
2016 · BMJ Open · 45 citations
https://doi.org/10.1136/bmjopen-2015-009956
Research priorities towards precision antibiotic therapy to improve patient care
2022 · The Lancet Microbe · 44 citations
https://doi.org/10.1016/s2666-5247(22)00121-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat